Congestive Heart Failure (CHF) in Dogs and Cats: Signs, MMVD vs. HCM, and Lifelong Treatment

"Doctor, my dog is 11 years old, a Cavalier, and lately, he's been coughing at night — it sounds like he's choking, usually around 2 or 3 in the morning. He's fine during the day and still wants to go for walks. But if I take him up the stairs, he gets tired very quickly and breathes rapidly. I thought it was just a normal cough, but my neighbor says it's a heart issue." This pattern — a senior small-breed dog + night cough + exercise intolerance — is classic MMVD (Myxomatous Mitral Valve Disease), the number one cause of CHF (Congestive Heart Failure) on dogs.

In cats, the presentation of heart failure is much more dramatic and late — owners often perceive their cat as "healthy" until they suddenly present with severe dyspnea (shortness of breath) or paralysis of the hind legs (saddle thrombus from ATE — a complication of HCM). This article is a comprehensive guide for owners — distinguishing dog MMVD vs. cat HCM, early signs that are often missed, diagnosis (echo + NT-proBNP + radiograph), lifelong treatment according to ACVIM protocols, and monitoring the sleeping respiratory rate at home.

What is CHF (Congestive Heart Failure)?

Heart failure is not a specific disease diagnosis — heart failure is the final syndrome of various heart diseases that cause the heart to fail to pump adequately, leading to fluid accumulation in the body (congestion). Fluid can back up into the lungs (pulmonary edema), the chest cavity (pleural effusion), the abdominal cavity (ascites), or a combination.

Important classifications:

• Left-sided CHF — backup into the lungs = pulmonary edema → dyspnea, coughing (dogs), tachypnea. Most common in dog MMVD and cat HCM.
• Right-sided CHF — backup into systemic veins = ascites + pleural effusion + jugular distension. More common in DCM, pulmonary hypertension, and pericardial disease.
• Biventricular — both, often in the end-stage.

CHF is a progressive, irreversible, and lifelong condition. Treatment aims to extend both the quality and quantity of life, not to cure the underlying disease. However, with proper management (ACVIM stage-based protocol), many animals can live with a good quality of life for years after the onset of CHF.

Dog CHF — predominately MMVD, secondary DCM

MMVD (Myxomatous Mitral Valve Disease) — the primary cause

MMVD is progressive mitral valve degeneration — the valve separating the left atrium and left ventricle becomes thick, irregular, and fails to close tightly. As a result, blood leaks back (regurgitation) when the ventricle contracts → the left atrium enlarges → progressing to pulmonary edema.

MMVD Demographics:

• Accounts for about 70-75% of dog heart disease.
• Predominantly small-to-medium breeds.
• Cavalier King Charles Spaniels — very high predisposition, often with MMVD onset at 5-6 years old, and a predisposition for early onset.
• Others: Chihuahua, Maltese, Miniature/Toy Poodle, Shih Tzu, Yorkshire Terrier, Dachshund, Pomeranian.
• Rare in giant breeds.
• Age of onset: middle-aged to senior (5+ years), prevalence increases significantly after 9 years.

DCM (Dilated Cardiomyopathy) — secondary in dogs

DCM is primary heart muscle weakness — the left ventricle (or both) becomes dilated and thin, and contractility drops drastically. Unlike MMVD, which is a valve problem, DCM is a problem with the heart muscle itself.

DCM Demographics:

• Predominantly large and giant breeds.
• Doberman Pinscher — very high predisposition, often onset at 6-8 years old, presentation is often sudden death or acute CHF without warning.
• Boxer — Boxer cardiomyopathy (a variant with prominent ventricular arrhythmias — ARVC).
• Others: Great Dane, Irish Wolfhound, Newfoundland, Cocker Spaniel.
• Onset often in middle age (3-7 years).
• Concerning trend: diet-associated DCM in atypical breeds fed grain-free / boutique / exotic ingredient diets — ongoing FDA monitoring.

Clinical signs of dog CHF

• Coughing — especially at night or early morning (when the owner lies flat, the dog is recumbent, and fluid distribution changes). Classic MMVD cough: dry "honking," often with coughing fits.
• Exercise intolerance — a dog that used to be strong on walks now gets tired after 5-10 minutes. Climbing stairs is often a trigger.
• Tachypnea — rapid breathing, especially at rest. A sleeping respiratory rate (SRR) of over 30 while sleeping is a red flag — even if the dog seems normal when awake.
• Syncope — brief fainting (collapsing for 5-10 seconds then recovering), often after excitement or heavy coughing. Indicates cardiac arrhythmia or severe disease.
• Abdominal distension — a distended belly from ascites (right-sided failure component).
• Cyanosis — bluish gums/tongue during severe dyspnea — an emergency.
• Heart murmur — if a doctor auscultates, they often hear a systolic murmur at the left apex (classic for MMVD). This can be detected YEARS BEFORE the onset of CHF — that's why senior screening is vital.

Cat CHF — predominately HCM, ATE as a complication

HCM (Hypertrophic Cardiomyopathy) — the most common

HCM is the thickening of the left ventricular muscle (concentric hypertrophy). The ventricle becomes thick, the cavity becomes small, and diastolic filling is compromised → the left atrium enlarges → progressing to pulmonary edema and/or pleural effusion + risk of thrombus formation in the dilated left atrium.

HCM Demographics:

• The most common heart disease in cats.
• Can occur in any breed, but predispositions exist in: Maine Coons (known MYBPC3 mutation), Ragdolls (different MYBPC3 mutation), British Shorthairs, Persians, and Sphynx.
• Domestic shorthairs (DSH) can also be affected — mixed breeds are not immune.
• Age of onset varies widely — from young (2-3 years) to senior.
• Many HCM cats are asymptomatic for years until they suddenly decompensate.

ATE (Arterial Thromboembolism) — saddle thrombus

A serious complication of HCM (and other cardiomyopathies). A thrombus forms in the dilated left atrium, dislodges, and blocks the terminal abdominal aorta (iliac bifurcation) — called a saddle thrombus. Result: acute hindlimb paralysis that is extremely painful, with no prior warning.

Classic ATE signs:

• Acute onset (within hours).
• Hind legs paralyzed or severely weak.
• Hind paw pads are cold and pale (vs. front paws which are warm).
• No femoral pulse in the back legs.
• Intense vocalization of pain (one of the most painful conditions in feline medicine).
• Dyspnea often co-exists (parallel HCM decompensation).

ATE is a true emergency. The prognosis is guarded — many cats are humanely euthanized as a compassionate choice. Those that survive the first 24-72 hours often see partial recovery over weeks, but recurrence is common.

Clinical signs of cat CHF — often subtle and late

Unlike dogs, cats with CHF are often asymptomatic until the late stages, then suddenly present acutely. What makes it tricky:

• Coughing is RARE in cats — coughing in cats is usually asthma/bronchitis, not heart-related.
• Tachypnea / dyspnea at rest — the most reliable sign, often acute decompensation.
• Open-mouth breathing — cats very rarely mouth-breathe; if seen, it is an emergency.
• Lethargy + anorexia — non-specific but often present.
• Saddle thrombus / ATE — acute hindlimb paralysis as the first presentation of previously undiagnosed HCM.
• Murmur — if a doctor auscultates, one is often present. But many HCM cases have no murmur (about 30%) — a normal auscultation does not rule out HCM.
• Gallop rhythm (S3 or S4) — more specific but harder to detect without experience.

Because cats are experts at hiding illness, proactive screening for predisposed breeds (Maine Coon, Ragdoll) before they get sick is invaluable.

Diagnosing CHF — multi-modal

1. Echocardiography (Echo) — the gold standard

An echo is the most important exam for diagnosing heart disease and staging. It evaluates:

• Heart valve structure and function (regurgitation in MMVD).
• Heart chamber sizes (left atrium, left ventricle).
• Ventricular wall thickness (hypertrophy in HCM).
• Ventricular contractility (systolic function — decreased in DCM).
• Diastolic function.
• Presence of a thrombus in the left atrium.
• Pleural effusion.

An echo requires a doctor with cardiology training or a veterinary cardiologist. Access to veterinary cardiologists in Indonesia is still limited — there are some in the Jabodetabek area, but other regions often require referrals.

2. Thoracic Radiograph (Chest X-ray)

• VHS (Vertebral Heart Score) — assessing if the heart size is normal or enlarged.
• Pulmonary edema patterns.
• Pleural effusion.
• Pulmonary congestion (distended pulmonary veins).
• Ruling out primary respiratory differentials.

Radiographs are valuable for confirming CHF (distinguishing it from primary respiratory disease) and monitoring treatment response.

3. NT-proBNP biomarker

NT-proBNP (N-terminal pro–B-type natriuretic peptide) is a blood biomarker that increases when the heart is stressed (dilated or hypertrophied). It is used for:

• Screening predisposed cat breeds (Maine Coon, Ragdoll) — detecting HCM before symptoms appear.
• Distinguishing between cardiac and respiratory dyspnea in cats — very useful because auscultation is often non-diagnostic.
• Monitoring treatment response.

It can be a rapid (SNAP) test or a quantitative lab test. It is more relevant for cats than for dogs.

4. ECG (Electrocardiogram)

• Detecting arrhythmias (atrial fibrillation in DCM, ventricular arrhythmia in Boxer cardiomyopathy, etc.).
• Monitoring during treatment.
• Not diagnostic for structural disease per se.

5. Blood panel + Blood pressure

• Baseline CBC + biochemistry + kidney function (important because heart meds affect the kidneys).
• Blood pressure (systemic hypertension can cause or worsen cardiac disease, especially in cats).
• T4 (for senior cats — hyperthyroidism can cause secondary cardiac changes).

ACVIM Staging — the basis for treatment decisions

The ACVIM Consensus on MMVD (updated 2019, revised 2024) classifies dog heart disease into stages, and the logic also applies to cats with modifications:

• Stage A — At risk (predisposed breed, no murmur yet). No treatment, just monitoring.
• Stage B1 — Structural disease without enlargement (murmur present but echo shows normal size). Annual monitoring, no treatment.
• Stage B2 — Structural disease with enlargement (enlarged left atrium/left ventricle) but no CHF yet. A pre-clinical phase that CAN be treated — pimobendan has been proven to extend the time until CHF onset (per the EPIC trial for dogs).
• Stage C — Past or current CHF. Lifelong multi-drug treatment.
• Stage D — Refractory end-stage. Intensive treatment, quality of life focus.

Treatment of CHF — multi-modal and lifelong

Pillar 1: Pimobendan (Vetmedin)

Pimobendan is an inodilator — it increases heart contractility (inotrope) + dilates blood vessels (vasodilator). According to Plumb's Veterinary Drug Handbook 7e, indications include dog MMVD Stage B2 + Stage C, DCM, and cat HCM with systolic dysfunction (classic HCM is systolic-preserved, but end-stage or atypical cases can use it).

• Per ACVIM Consensus 2019/2024: pimobendan is first-line for dogs with MMVD stage B2 (preclinical) and stage C+.
• EPIC trial: pimobendan delays CHF onset in dogs with MMVD stage B2.
• Dosing and monitoring according to Plumb's 7e: monitoring kidney function and electrolytes.

Pillar 2: Furosemide (Lasix)

Furosemide is a loop diuretic — it removes excess fluid from the body via the kidneys, reducing pulmonary edema and effusion. It is a cornerstone for Stage C+ CHF.

• Dose and frequency per Plumb's 7e depend on severity and response.
• Monitoring: kidney function, electrolytes (especially K+, which often drops), and hydration.
• Owners must monitor the sleeping respiratory rate (SRR) — if it rises above 30, a dose adjustment may be necessary.
• Torasemide is an alternative for refractory cases (more potent).

Pillar 3: ACE inhibitors

ACE inhibitors (enalapril, benazepril) — reduce heart afterload + suppress the renin-angiotensin system that is active in CHF.

• Benazepril is often preferred for animals with renal impairment (mostly hepatic clearance).
• Dosing and monitoring per Plumb's 7e.
• Monitoring: kidney function (creatinine may rise) and blood pressure.

Pillar 4: Spironolactone

Spironolactone is an aldosterone antagonist — a weak diuretic but with cardiac remodeling benefits. According to ACVIM Consensus 2019/2024 for dogs with MMVD stage C+, spironolactone is recommended as an adjunct.

Cat-specific pillar: Clopidogrel anti-thrombotic

For cats with HCM (especially if there is left atrial enlargement or spontaneous echo contrast / "smoke," which are predictors of thrombus formation):

• Clopidogrel — an antiplatelet drug proven superior to aspirin for ATE prevention in the FATCAT study.
• Dosing according to Plumb's Veterinary Drug Handbook 7e.
• Used long-term for saddle thrombus prevention in high-risk HCM cats.

Others per Plumb's 7e

• Telmisartan — an angiotensin receptor blocker, an alternative or adjunct to ACE-i (especially for cats with comorbid systemic hypertension).
• Sildenafil — for comorbid pulmonary hypertension (common in dogs with advanced MMVD).
• Atenolol — a beta-blocker, sometimes used in cat HCM with outflow obstruction (ongoing controversy regarding benefit) — discuss with a cardiologist.
• Taurine supplementation for cat DCM — some cases of cat DCM are caused by taurine deficiency and are reversible with supplementation. Idiopathic cat DCM is relatively rare now as commercial diets are taurine-fortified, but screening is still important.

Monitoring at home — Sleeping Respiratory Rate (SRR)

One of the most valuable and SIMPLE monitoring tools for owners is the sleeping respiratory rate — counting the pet's breaths during deep sleep (not while dreaming/REM).

Per the landmark Ljungvall et al. 2014 study (dogs) and subsequent feline studies, an SRR of over 30 breaths per minute while the pet sleeps calmly is a red flag — a sensitive predictor of developing pulmonary edema or effusion, often PRECEDING overt clinical symptoms.

How to calculate SRR at home

1. Wait for the pet to sleep calmly (not dreaming with a twitching body).
2. Count one breathing cycle (inhalation + exhalation) as one.
3. Count for 15 seconds and multiply by 4 — or count for a full 60 seconds.
4. Record in a daily journal or app (there are several free apps like "Cardalis" or "Sleeping Respiratory Rate").

Concerning patterns

• SRR consistently below 30 → stable.
• SRR rises suddenly to 35-40+ → likely decompensation, contact your doctor.
• SRR fluctuates but trends upwards gradually over several days → a dose adjustment may be needed.

This simple tool can save lives — many decompensation cases are detected early and treated before presenting in an emergency.

CHF Prognosis

Dog MMVD

• Stage B2 with pimobendan: significant median delay in CHF onset (per EPIC trial).
• Stage C onset: median survival varies widely — months to years depending on treatment response, comorbidities, and compliance.
• Good prognostic factors: fast response to initial treatment, owner compliance, access to regular rechecks.
• Poor prognostic factors: comorbid pulmonary hypertension, atrial fibrillation, frequent syncope, rising creatinine (kidney impairment).

Dog DCM

• Prognosis is more guarded than for MMVD due to primary contractility drop.
• Dobermans: median survival from CHF onset may be months, though some live longer with optimal treatment.
• Significant risk of sudden death from arrhythmias.

Cat HCM

• Asymptomatic cats with HCM can live stably for years with monitoring.
• CHF onset: median survival varies widely based on severity, treatment response, and complications (ATE).
• HCM cats with ATE as the first presentation: poor prognosis — many are humanely euthanized; survivors often have recurrences.
• Severe left atrial enlargement: high ATE risk → preventive clopidogrel.

End-of-life decisions — sensitive but important

CHF is a progressive disease. While treatment can significantly extend the quality of life, many pets eventually reach a refractory stage where fluid can no longer be adequately controlled with medication. At that point, the owner and doctor need to discuss:

• The pet's quality of life — can they still enjoy eating, moving, and family interaction?
• The severity of dyspnea — "air hunger" is significant suffering.
• Response to rescue therapy (dose escalation, additional drugs) — is there still any response?
• Humane euthanasia as a compassionate choice if the quality of life has collapsed.

This discussion is heavy but important to start before a midnight emergency crisis. Many owners of advanced CHF pets find peace in having a clear plan with their doctor — including discussing home euthanasia options when the time comes.

CHF FAQ

My dog is a Cavalier, 8 years old, and the doctor heard a murmur. Does he need treatment now?

Depends on the stage (per ACVIM): if Stage B1 (murmur without enlargement on echo), no treatment, only annual monitoring. If Stage B2 (murmur + enlargement), pimobendan has been proven to extend the time to CHF onset (EPIC trial). An echo is mandatory for accurate staging — a murmur alone does not determine treatment.

My cat is a Maine Coon, healthy; do they need heart screening?

Yes, it's highly recommended. Maine Coons have a significant predisposition to HCM (MYBPC3 mutation). Screening with an echo (preferred) or a rapid NT-proBNP test can detect pre-clinical HCM. Many HCM Maine Coons are asymptomatic for years — early detection allows for proactive monitoring and intervention before complications like ATE.

Can CHF dogs exercise?

Stage C+ — limited exercise. Avoid high-intensity (climbing stairs, fast running, excessive heat). Calm walking is OK if the animal tolerates it without dyspnea or excessive coughing. Listen to the animal — if they stop on their own, don't force them.

Is a special diet needed for CHF dogs/cats?

For CHF dogs, a low-sodium diet helps (reduces fluid retention). Commercial cardiac diets (Hill's h/d, Royal Canin Cardiac) are available. Avoid high-salt treats (human food, processed). For cats, low-sodium diets are controversial — palatability often drops, and a cat with anorexia due to unpalatable food is much worse than a little extra sodium. Discuss with your doctor.

Do these medications have severe side effects?

All heart medications have potential side effects, especially those affecting the kidneys (furosemide, ACE inhibitors). Regular blood panel monitoring (3-6 months) is mandatory. Common issues: dehydration from excessive furosemide, mild azotemia (rising creatinine) from ACE-i, and hypokalemia (low K+) from diuretics. Adjust doses with your doctor; do not stop medications yourself — sudden withdrawal can trigger acute decompensation.

How long can my dog/cat live after a CHF diagnosis?

Variation is very wide depending on the disease type, stage at diagnosis, treatment response, and compliance. MMVD dogs with optimal treatment often live months to years after CHF onset. Cat HCM varies widely. Avoid specific prognoses without echo staging — ask your doctor to discuss the expected timeline based on your pet's specific condition.

How much does a CHF workup and treatment cost?

The cost of a CHF workup and treatment cannot be quoted as a single figure — it depends on several factors: the type and stage of disease, the facility and cardiologist access for the echo, the lifelong drug combination (pimobendan + furosemide + ACE-i + spironolactone) whose doses are adjusted to the animal's weight and response, and the frequency of periodic monitoring (blood panel + echo recheck every 3-6 months). For that reason, the most accurate estimate comes after the animal has been evaluated. Contact Prabasavet on WhatsApp for a free consultation — tell us about your pet's condition and we'll help explain the evaluation plan and an outline of the costs.

Summary

CHF is a heart failure syndrome with fluid backup into the lungs, chest, or abdomen. In dogs: MMVD (mitral valve disease) is most common, especially in Cavaliers and other small breeds, presenting with night cough + exercise intolerance. DCM (dilated cardiomyopathy) occurs in large breeds like Dobermans and Boxers, presenting with sudden onset or syncope. In cats: HCM (hypertrophic cardiomyopathy) is most common, including predisposed Maine Coons and Ragdolls, often presenting as asymptomatic until sudden dyspnea or saddle thrombus (ATE).

Diagnosis: Echo (gold standard) + radiograph + NT-proBNP biomarker (especially for cats) + ECG if an arrhythmia is present. ACVIM staging (Stage A → D) guides treatment.

Lifelong multi-modal treatment: pimobendan + furosemide + ACE inhibitors (enalapril/benazepril) + spironolactone for CHF dogs; clopidogrel anti-thrombotic for HCM cats at risk of ATE. Home monitoring of the sleeping respiratory rate (target under 30) is a simple but invaluable tool. Prognosis varies, but with proper management, many animals live with good quality for years. End-of-life discussions are important before an emergency crisis occurs.

Is your dog coughing at night + getting tired quickly? Have a predisposed cat like a Maine Coon or Ragdoll? See Prabasavet's pet care guide or contact our WhatsApp to consult on a cardiology evaluation plan.

Read also: Signs of Cat Sickness That Need a Doctor, Emergency Signs in Cats, Senior Dogs: Changes and Senior Care.

---

Medical references used in this article

This article was compiled referring to the following sources, verified per clinical sentence:

• ACVIM Consensus Statement on the Diagnosis and Treatment of Myxomatous Mitral Valve Disease in Dogs (2019 + 2024 update) — A/B1/B2/C/D staging, treatment protocol per stage, early pimobendan intervention (EPIC trial), spironolactone adjunct, and monitoring guidelines.
• ACVIM Consensus Statement on Hypertrophic Cardiomyopathy in Cats (2020) — HCM diagnostic criteria, staging, treatment paradigm, ATE risk stratification, and preventive clopidogrel (FATCAT study reference).
• Boswood A et al. EPIC trial — Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly — pimobendan delays CHF onset in stage B2 MMVD dogs.
• Ljungvall I et al. 2014 — sleeping respiratory rate as a monitoring tool for CHF, threshold over 30 as a decompensation predictor, validated in dogs.
• BSAVA Manual of Canine and Feline Cardiorespiratory Medicine — diagnostic approach, echo + radiograph + NT-proBNP biomarker, dog MMVD vs DCM differential, and cat HCM + RCM + DCM classification, ATE management.
• Plumb's Veterinary Drug Handbook, 7th Edition — dosage references for pimobendan, furosemide, enalapril/benazepril, spironolactone, clopidogrel, telmisartan, sildenafil, atenolol, and taurine for cat DCM; blood panel monitoring requirements.
• Hogan DF et al. FATCAT study — Feline Arterial Thromboembolism: Clopidogrel vs Aspirin Trial — clopidogrel proven superior for ATE recurrence prevention in cats.

This article is a general guide based on international ACVIM and BSAVA guidelines. For your pet's specific condition — including disease stage, treatment response, comorbidities, and prognosis timeline — consulting a veterinarian and, if possible, a veterinary cardiologist is the right step. CHF treatment requires adjustments over time with proper monitoring.